<code id='ABDF0E2866'></code><style id='ABDF0E2866'></style>
    • <acronym id='ABDF0E2866'></acronym>
      <center id='ABDF0E2866'><center id='ABDF0E2866'><tfoot id='ABDF0E2866'></tfoot></center><abbr id='ABDF0E2866'><dir id='ABDF0E2866'><tfoot id='ABDF0E2866'></tfoot><noframes id='ABDF0E2866'>

    • <optgroup id='ABDF0E2866'><strike id='ABDF0E2866'><sup id='ABDF0E2866'></sup></strike><code id='ABDF0E2866'></code></optgroup>
        1. <b id='ABDF0E2866'><label id='ABDF0E2866'><select id='ABDF0E2866'><dt id='ABDF0E2866'><span id='ABDF0E2866'></span></dt></select></label></b><u id='ABDF0E2866'></u>
          <i id='ABDF0E2866'><strike id='ABDF0E2866'><tt id='ABDF0E2866'><pre id='ABDF0E2866'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:entertainment    Page View:47495
          People waiting in line, standing in between red rope. -- first opinion coverage from STAT
          Adobe

          Health care providers and health insurance companies are closing the books on their third quarters, and one major question continues to hang over them: How much care is everyone actually getting, now that Covid-19 isn’t scaring so many away from doctors and hospitals?

          The short answer, according to financial analysts and the companies themselves: It appears people continue to fill prescriptions, see their doctors, and get recommended surgeries.

          advertisement

          For health insurers, those trends mean they will have to deposit more money into the bank accounts of providers — perhaps more than they predicted.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          George Santos makes 1st court appearance after pleading not guilty to 13 counts
          George Santos makes 1st court appearance after pleading not guilty to 13 counts

          1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

          read more
          Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial
          Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCJapanesedrugmakerNipponShinyakusaidon

          read more
          New air purifier tech could be key to improving indoor air quality
          New air purifier tech could be key to improving indoor air quality

          AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

          read more

          Why we need mandatory labeling of GMO products

          TIMOTHYA.CLARY/AFPviaGettyImagesTheconversationaroundgeneticengineeringandfoodisunderminedbyalackofi